#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hyperadrenocorticism Fibrous dysplasia of bone Head and neck cancer Stevens-Johnson syndrome Hodgkin's disease refractory Toxic epidermal necrolysis C3 glomerulopathy Activated PI3 kinase delta syndrome Pulmonary tuberculosis Vascular calcification Ovarian cancer Deafness bilateral Hypochondroplasia Pyoderma gangrenosum Progressive supranuclear palsy More trials…

    Learn about Rare Diseases

    Familial haemophagocytic lymphohistiocytosis – Trials in Disease Tuberous sclerosis complex – Life with Disease Alport’s syndrome – Life with Disease Splenic marginal zone lymphoma Alternating hemiplegia of childhood – Trials in Disease Phenylketonuria – Trials in Disease Andersen-Tawil syndrome – Basic Information Chordoma – Diagnostics Wiskott-Aldrich syndrome – Basic Information Malignant fibrous histiocytoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Linezolid Metoprolol Succinate PIPOTIAZINE Octreotide Acetate Diclofenac Diethylamine Benralizumab GSKVX000000044501 Hydrocortisone Acetate Imidapril Hydrochloride Tepotinib Levofloxacin Pamiparib Zinc Acetate Dihydrate Quetiapine ZIRCONIUM (89ZR) GIRENTUXIMAB Apixaban Jnj-64042056 Pitolisant Bay 3283142 Aflibercept More therapies…

    Learn about Your Condition

    Epilepsy Cervix carcinoma Paget's disease of the vulva Haemorrhage Anal incontinence Craniocerebral injury Hypoalbuminaemia Malabsorption Migraine with aura Merycism Anal fistula Malignant oligodendroglioma Myocardial ischaemia Affective disorder Coronary artery dissection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Esmolol for Heart Issues in Patients with Cirrhosis, Diabetes, or Cardiotoxic Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiovascular disorder
    Investigated Drugs:
    • Esmolol Hydrochloride
    Spain
  • Study on Dapagliflozin for Patients with Decompensated Liver Cirrhosis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cirrhosis alcoholic
    • Hepatic cirrhosis
    Investigated Drugs:
    • Dapagliflozin
    Italy
  • Study on Clobetasol Propionate and Prednisolone Acetate for Treating Eye Inflammation After Cataract Surgery in Children Aged 0-3 Years

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Eye inflammation
    • Eye pain
    Investigated Drugs:
    • Clobetasol Propionate
    • Prednisolone Acetate
    Spain
  • Study on the Effectiveness of Doxorubicin, Ifosfamide, and Dacarbazine in High-Risk Soft Tissue Sarcoma Patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dacarbazine Citrate
    • Ifosfamide
    • Doxorubicin
    France
  • Study on Rosuvastatin and Placebo for Patients with Statin Intolerance and High Cardiovascular Risk

    Recruiting

    3 1
    Investigated Drugs:
    • Rosuvastatin Calcium
    The Netherlands
  • Study on the Early Effects of Ketamine and Venlafaxine for Hospitalized Patients with Severe Major Depression

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • (4R)-1-[(3-(11C)Methylpyridin-4-Yl)Methyl]-4-(3,4,5-Trifluorophenyl)Pyrrolidin-2-One
    • Venlafaxine
    • Ketamine
    France
Previous Page
1 … 515 516 517 518 519 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!